Global Endometrial Cancer Market Research Report 2023

Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to Others parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Others symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.

The global Endometrial Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The endometrial cancer market is dominated by North America owing to the rising prevalence of breast cancer.

This report aims to provide a comprehensive presentation of the global market for Endometrial Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endometrial Cancer.

The Endometrial Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Endometrial Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Endometrial Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Endometrial Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Hysterectomy Techniques

1.2.3 Radiation

1.2.4 Hormone Therapy

1.2.5 ChemOthersapy

1.3 Market by Application

1.3.1 Global Endometrial Cancer Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Gynecology Centers

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Endometrial Cancer Market Perspective (2018-2029)

2.2 Endometrial Cancer Growth Trends by Region

2.2.1 Global Endometrial Cancer Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Endometrial Cancer Historic Market Size by Region (2018-2023)

2.2.3 Endometrial Cancer Forecasted Market Size by Region (2024-2029)

2.3 Endometrial Cancer Market Dynamics

2.3.1 Endometrial Cancer Industry Trends

2.3.2 Endometrial Cancer Market Drivers

2.3.3 Endometrial Cancer Market Challenges

2.3.4 Endometrial Cancer Market Restraints

3.1 Global Top Endometrial Cancer Players by Revenue

3.1.1 Global Top Endometrial Cancer Players by Revenue (2018-2023)

3.1.2 Global Endometrial Cancer Revenue Market Share by Players (2018-2023)

3.2 Global Endometrial Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Endometrial Cancer Revenue

3.4 Global Endometrial Cancer Market Concentration Ratio

3.4.1 Global Endometrial Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Endometrial Cancer Revenue in 2022

3.5 Endometrial Cancer Key Players Head office and Area Served

3.6 Key Players Endometrial Cancer Product Solution and Service

3.7 Date of Enter into Endometrial Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Endometrial Cancer Historic Market Size by Type (2018-2023)

4.2 Global Endometrial Cancer Forecasted Market Size by Type (2024-2029)

5.1 Global Endometrial Cancer Historic Market Size by Application (2018-2023)

5.2 Global Endometrial Cancer Forecasted Market Size by Application (2024-2029)

6.1 North America Endometrial Cancer Market Size (2018-2029)

6.2 North America Endometrial Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Endometrial Cancer Market Size by Country (2018-2023)

6.4 North America Endometrial Cancer Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Endometrial Cancer Market Size (2018-2029)

7.2 Europe Endometrial Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Endometrial Cancer Market Size by Country (2018-2023)

7.4 Europe Endometrial Cancer Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Endometrial Cancer Market Size (2018-2029)

8.2 Asia-Pacific Endometrial Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Endometrial Cancer Market Size by Region (2018-2023)

8.4 Asia-Pacific Endometrial Cancer Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Endometrial Cancer Market Size (2018-2029)

9.2 Latin America Endometrial Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Endometrial Cancer Market Size by Country (2018-2023)

9.4 Latin America Endometrial Cancer Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Endometrial Cancer Market Size (2018-2029)

10.2 Middle East & Africa Endometrial Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Endometrial Cancer Market Size by Country (2018-2023)

10.4 Middle East & Africa Endometrial Cancer Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Endometrial Cancer Introduction

11.1.4 Pfizer Revenue in Endometrial Cancer Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Endometrial Cancer Introduction

11.2.4 Johnson & Johnson Revenue in Endometrial Cancer Business (2018-2023)

11.2.5 Johnson & Johnson Recent Development

11.3 Boston Scientific

11.3.1 Boston Scientific Company Detail

11.3.2 Boston Scientific Business Overview

11.3.3 Boston Scientific Endometrial Cancer Introduction

11.3.4 Boston Scientific Revenue in Endometrial Cancer Business (2018-2023)

11.3.5 Boston Scientific Recent Development

11.4 GE

11.4.1 GE Company Detail

11.4.2 GE Business Overview

11.4.3 GE Endometrial Cancer Introduction

11.4.4 GE Revenue in Endometrial Cancer Business (2018-2023)

11.4.5 GE Recent Development

11.5 Karl Storz

11.5.1 Karl Storz Company Detail

11.5.2 Karl Storz Business Overview

11.5.3 Karl Storz Endometrial Cancer Introduction

11.5.4 Karl Storz Revenue in Endometrial Cancer Business (2018-2023)

11.5.5 Karl Storz Recent Development

11.6 Koninklijke Philips

11.6.1 Koninklijke Philips Company Detail

11.6.2 Koninklijke Philips Business Overview

11.6.3 Koninklijke Philips Endometrial Cancer Introduction

11.6.4 Koninklijke Philips Revenue in Endometrial Cancer Business (2018-2023)

11.6.5 Koninklijke Philips Recent Development

11.7 Celgene

11.7.1 Celgene Company Detail

11.7.2 Celgene Business Overview

11.7.3 Celgene Endometrial Cancer Introduction

11.7.4 Celgene Revenue in Endometrial Cancer Business (2018-2023)

11.7.5 Celgene Recent Development

11.8 Lupin

11.8.1 Lupin Company Detail

11.8.2 Lupin Business Overview

11.8.3 Lupin Endometrial Cancer Introduction

11.8.4 Lupin Revenue in Endometrial Cancer Business (2018-2023)

11.8.5 Lupin Recent Development

11.9 LiNA Medical

11.9.1 LiNA Medical Company Detail

11.9.2 LiNA Medical Business Overview

11.9.3 LiNA Medical Endometrial Cancer Introduction

11.9.4 LiNA Medical Revenue in Endometrial Cancer Business (2018-2023)

11.9.5 LiNA Medical Recent Development

11.10 Bayer AG

11.10.1 Bayer AG Company Detail

11.10.2 Bayer AG Business Overview

11.10.3 Bayer AG Endometrial Cancer Introduction

11.10.4 Bayer AG Revenue in Endometrial Cancer Business (2018-2023)

11.10.5 Bayer AG Recent Development

11.11 Cooper Surgical

11.11.1 Cooper Surgical Company Detail

11.11.2 Cooper Surgical Business Overview

11.11.3 Cooper Surgical Endometrial Cancer Introduction

11.11.4 Cooper Surgical Revenue in Endometrial Cancer Business (2018-2023)

11.11.5 Cooper Surgical Recent Development

11.12 Hologic

11.12.1 Hologic Company Detail

11.12.2 Hologic Business Overview

11.12.3 Hologic Endometrial Cancer Introduction

11.12.4 Hologic Revenue in Endometrial Cancer Business (2018-2023)

11.12.5 Hologic Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Endometrial Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Hysterectomy Techniques

    Table 3. Key Players of Radiation

    Table 4. Key Players of Hormone Therapy

    Table 5. Key Players of ChemOthersapy

    Table 6. Global Endometrial Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Endometrial Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Endometrial Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Endometrial Cancer Market Share by Region (2018-2023)

    Table 10. Global Endometrial Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Endometrial Cancer Market Share by Region (2024-2029)

    Table 12. Endometrial Cancer Market Trends

    Table 13. Endometrial Cancer Market Drivers

    Table 14. Endometrial Cancer Market Challenges

    Table 15. Endometrial Cancer Market Restraints

    Table 16. Global Endometrial Cancer Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Endometrial Cancer Market Share by Players (2018-2023)

    Table 18. Global Top Endometrial Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometrial Cancer as of 2022)

    Table 19. Ranking of Global Top Endometrial Cancer Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Endometrial Cancer Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Endometrial Cancer Product Solution and Service

    Table 23. Date of Enter into Endometrial Cancer Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Endometrial Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Endometrial Cancer Revenue Market Share by Type (2018-2023)

    Table 27. Global Endometrial Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Endometrial Cancer Revenue Market Share by Type (2024-2029)

    Table 29. Global Endometrial Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Endometrial Cancer Revenue Market Share by Application (2018-2023)

    Table 31. Global Endometrial Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Endometrial Cancer Revenue Market Share by Application (2024-2029)

    Table 33. North America Endometrial Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Endometrial Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Endometrial Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Endometrial Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Endometrial Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Endometrial Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Endometrial Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Endometrial Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Endometrial Cancer Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Endometrial Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Endometrial Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Endometrial Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Endometrial Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Endometrial Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Endometrial Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Pfizer Company Detail

    Table 49. Pfizer Business Overview

    Table 50. Pfizer Endometrial Cancer Product

    Table 51. Pfizer Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 52. Pfizer Recent Development

    Table 53. Johnson & Johnson Company Detail

    Table 54. Johnson & Johnson Business Overview

    Table 55. Johnson & Johnson Endometrial Cancer Product

    Table 56. Johnson & Johnson Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 57. Johnson & Johnson Recent Development

    Table 58. Boston Scientific Company Detail

    Table 59. Boston Scientific Business Overview

    Table 60. Boston Scientific Endometrial Cancer Product

    Table 61. Boston Scientific Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 62. Boston Scientific Recent Development

    Table 63. GE Company Detail

    Table 64. GE Business Overview

    Table 65. GE Endometrial Cancer Product

    Table 66. GE Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 67. GE Recent Development

    Table 68. Karl Storz Company Detail

    Table 69. Karl Storz Business Overview

    Table 70. Karl Storz Endometrial Cancer Product

    Table 71. Karl Storz Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 72. Karl Storz Recent Development

    Table 73. Koninklijke Philips Company Detail

    Table 74. Koninklijke Philips Business Overview

    Table 75. Koninklijke Philips Endometrial Cancer Product

    Table 76. Koninklijke Philips Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 77. Koninklijke Philips Recent Development

    Table 78. Celgene Company Detail

    Table 79. Celgene Business Overview

    Table 80. Celgene Endometrial Cancer Product

    Table 81. Celgene Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 82. Celgene Recent Development

    Table 83. Lupin Company Detail

    Table 84. Lupin Business Overview

    Table 85. Lupin Endometrial Cancer Product

    Table 86. Lupin Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 87. Lupin Recent Development

    Table 88. LiNA Medical Company Detail

    Table 89. LiNA Medical Business Overview

    Table 90. LiNA Medical Endometrial Cancer Product

    Table 91. LiNA Medical Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 92. LiNA Medical Recent Development

    Table 93. Bayer AG Company Detail

    Table 94. Bayer AG Business Overview

    Table 95. Bayer AG Endometrial Cancer Product

    Table 96. Bayer AG Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 97. Bayer AG Recent Development

    Table 98. Cooper Surgical Company Detail

    Table 99. Cooper Surgical Business Overview

    Table 100. Cooper Surgical Endometrial Cancer Product

    Table 101. Cooper Surgical Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 102. Cooper Surgical Recent Development

    Table 103. Hologic Company Detail

    Table 104. Hologic Business Overview

    Table 105. Hologic Endometrial Cancer Product

    Table 106. Hologic Revenue in Endometrial Cancer Business (2018-2023) & (US$ Million)

    Table 107. Hologic Recent Development

    Table 108. Research Programs/Design for This Report

    Table 109. Key Data Information from Secondary Sources

    Table 110. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Endometrial Cancer Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Endometrial Cancer Market Share by Type: 2022 VS 2029

    Figure 3. Hysterectomy Techniques Features

    Figure 4. Radiation Features

    Figure 5. Hormone Therapy Features

    Figure 6. ChemOthersapy Features

    Figure 7. Global Endometrial Cancer Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Endometrial Cancer Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Case Studies

    Figure 10. Clinics Case Studies

    Figure 11. Gynecology Centers Case Studies

    Figure 12. Others Case Studies

    Figure 13. Endometrial Cancer Report Years Considered

    Figure 14. Global Endometrial Cancer Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Endometrial Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Endometrial Cancer Market Share by Region: 2022 VS 2029

    Figure 17. Global Endometrial Cancer Market Share by Players in 2022

    Figure 18. Global Top Endometrial Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometrial Cancer as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Endometrial Cancer Revenue in 2022

    Figure 20. North America Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Endometrial Cancer Market Share by Country (2018-2029)

    Figure 22. United States Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Endometrial Cancer Market Share by Country (2018-2029)

    Figure 26. Germany Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Endometrial Cancer Market Share by Region (2018-2029)

    Figure 34. China Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Endometrial Cancer Market Share by Country (2018-2029)

    Figure 42. Mexico Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Endometrial Cancer Market Share by Country (2018-2029)

    Figure 46. Turkey Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Endometrial Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Pfizer Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 49. Johnson & Johnson Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 50. Boston Scientific Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 51. GE Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 52. Karl Storz Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 53. Koninklijke Philips Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 54. Celgene Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 55. Lupin Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 56. LiNA Medical Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 57. Bayer AG Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 58. Cooper Surgical Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 59. Hologic Revenue Growth Rate in Endometrial Cancer Business (2018-2023)

    Figure 60. Bottom-up and Top-down Approaches for This Report

    Figure 61. Data Triangulation

    Figure 62. Key Executives Interviewed